Assessment of biotechnologies can be a daunting task. Separating commercializable opportunities from basic research projects and novelty from incremental improvement is a time consuming challenge. Lybradyn provides experience tailored to efficiently delivering concise, professional and objective evaluations of technology in the following areas:
- Biocatalysis
- Bioenergy
- Bionanomaterials
- Genetic engineering
- Metabolic engineering
- Protein expression
- Synthetic biology
Lybradyn also offers unique, rapid, and confidential “in lab” critical path studies that can independently evaluate technology and product opportunities.
